The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells.
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not...
Geley, S; Hartmann, B L; Kapelari, K; Egle, A; Villunger, A; Heidacher, D; Greil, R; Auer, B; Kofler, R
1997-02-20 00:00:00
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngFEBS LettersPubmedhttp://www.deepdyve.com/lp/pubmed/the-interleukin-1beta-converting-enzyme-inhibitor-crma-prevents-apo1-1IGGo1bRNn
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells.
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.